Remote Exercise Program for Patients With Metastatic Renal Cell Carcinoma Undergoing Immunotherapy: An EXIO Case Series Report
An innovative approach to patient care.
FDA Issues Partial Clinical Hold on Lorigerlimab Trial in Gynecologic Cancers
A recent FDA decision suspends the trial of Lorigerlimab due to safety concerns, highlighting the regulatory body’s commitment to ensuring the safety of medical trials.
Refining Management of Immune-Checkpoint Inhibitor Toxicities in Melanoma
A focus on improving melanoma treatment management is crucial in our fight against this potentially deadly skin cancer. Reducing side effects not only increases patient comfort but may also enhance overall treatment efficacy.
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma
In the mission to accelerate promising cancer treatments, the FDA has granted fast track designation to SRN-101 for the treatment of high-grade glioma, a dangerous type of brain tumor.
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma
The use of a new small molecule in multiple myeloma treatment shines a ray of hope. Early responses indicate potential for further pursuit.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC
In a comparative study of protons and photons in the treatment of OPSCC, quality of life outcomes took center stage, underscoring the importance of patient well-being in oncology.
